Stock comparison
Side-by-side financials for CLGN and STE. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
STE is larger
Market cap data is available for the leading company in this comparison.
Market value leader
STE
Latest market capitalization comparison.
Revenue leader
STE
CLGN: $2.37M vs STE: $5.46B.
Profit leader
STE
CLGN: -$11.49M vs STE: $614.64M.
Margin leader
STE
CLGN: -484.6% vs STE: 11.3% net margin.
| Metric | CLGN | STE |
|---|---|---|
| Market cap | - | $21.18 B |
| US-listed rank | - | #607 |
| Revenue (latest FY) | $2.37M | $5.46B |
| Net income (latest FY) | -$11.49M | $614.64M |
| Net margin | -484.6% | 11.3% |
| P/E (trailing FY) | - | 34.5x |
| SEC filings | 317 | 614 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, CollPlant Biotechnologies Ltd reported $2.37M in revenue while STERIS plc reported $5.46B.
Full pages: CollPlant Biotechnologies Ltd and STERIS plc, or browse the full rankings.